Shares of Willow Biosciences Inc. (TSE:WLLW – Get Free Report) were down 12.5% on Thursday . The company traded as low as C$0.04 and last traded at C$0.04. Approximately 164,688 shares were traded during trading, a decline of 69% from the average daily volume of 523,611 shares. The stock had previously closed at C$0.04.
Willow Biosciences Stock Performance
The business’s 50-day moving average price is C$0.05 and its 200-day moving average price is C$0.08. The stock has a market cap of C$5.07 million, a PE ratio of -0.64 and a beta of 1.13. The company has a current ratio of 0.80, a quick ratio of 19.71 and a debt-to-equity ratio of 902.05.
About Willow Biosciences
Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.
Featured Articles
- Five stocks we like better than Willow Biosciences
- 3 Warren Buffett Stocks to Buy Now
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Warren Buffett Stocks to Buy Now
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Compound Interest and Why It Matters When Investing
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
